Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3490690015 | Product containing nilutamide (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3715920010 | Nilutamide-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nilutamide-containing product | Is a | Androgen receptor antagonist-containing product | true | Inferred relationship | Some | ||
| Nilutamide-containing product | Is a | Imidazolidinone-containing product | true | Inferred relationship | Some | ||
| Nilutamide-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Nilutamide-containing product | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Nilutamide-containing product | Is a | Synthetic antiandrogen-containing product | false | Inferred relationship | Some | ||
| Nilutamide-containing product | Has active ingredient | Hormones and their metabolites and precursors | false | Inferred relationship | Some | ||
| Nilutamide-containing product | Has active ingredient | Nilutamide | true | Inferred relationship | Some | 1 | |
| Nilutamide-containing product | Is a | Hormone receptor antagonist-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nilutamide-containing product in oral dose form | Is a | True | Nilutamide-containing product | Inferred relationship | Some | |
| Nilutamide only product | Is a | True | Nilutamide-containing product | Inferred relationship | Some | |
| Nilutamide 150 mg oral tablet | Is a | False | Nilutamide-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR